BCG in subjects infected with HIV.
Guerin
N
N
International Children's Centre, Paris, France.
D001500:BCG Vaccine / Q000009:adverse effects / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications*; D015497:HIV-1; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008199:Lymphadenitis / Q000139:chemically induced* / Q000150:complications / Q000453:epidemiology; D012307:Risk Factors
D001500:BCG Vaccine